# A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis.

> **NCT00365001** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 23 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** tocilizumab [RoActemra/Actemra]
- **DRUG:** Methotrexate
- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT00365001
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2008-04
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2010-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00365001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00365001, "A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis.". Retrieved via AI Analytics 2026-08-20 from https://api.ai-analytics.org/clinical/NCT00365001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*